These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28915107)

  • 1. Selective changes in cholesterol metabolite levels in plasma of breast cancer patients after tumor removal.
    Soucek P; Vrana D; Ueng YF; Wei S; Kozevnikovova R; Guengerich FP
    Clin Chem Lab Med; 2018 Feb; 56(3):e78-e81. PubMed ID: 28915107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma oxysterol levels in luminal subtype breast cancer patients are associated with clinical data.
    Kloudova-Spalenkova A; Ueng YF; Wei S; Kopeckova K; Peter Guengerich F; Soucek P
    J Steroid Biochem Mol Biol; 2020 Mar; 197():105566. PubMed ID: 31874216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol, Oxysterols and LXRs in Breast Cancer Pathophysiology.
    Nazih H; Bard JM
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between estradiol, estrogen receptors, total lipids, triglycerides, and cholesterol in patients with benign and malignant breast tumors.
    Mady EA
    J Steroid Biochem Mol Biol; 2000 Dec; 75(4-5):323-8. PubMed ID: 11282289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes.
    Lappano R; Recchia AG; De Francesco EM; Angelone T; Cerra MC; Picard D; Maggiolini M
    PLoS One; 2011 Jan; 6(1):e16631. PubMed ID: 21304949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol derivatives and breast cancer: oxysterols driving tumor growth and metastasis.
    Sawada MI; S Ferreira GD; Passarelli M
    Biomark Med; 2020 Oct; 14(14):1299-1302. PubMed ID: 32969241
    [No Abstract]   [Full Text] [Related]  

  • 7. The emerging role of 27-hydroxycholesterol in cancer development and progression: An update.
    Abdalkareem Jasim S; Kzar HH; Haider Hamad M; Ahmad I; Al-Gazally ME; Ziyadullaev S; Sivaraman R; Abed Jawad M; Thaeer Hammid A; Oudaha KH; Karampoor S; Mirzaei R
    Int Immunopharmacol; 2022 Sep; 110():109074. PubMed ID: 35978522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study.
    Dalenc F; Iuliano L; Filleron T; Zerbinati C; Voisin M; Arellano C; Chatelut E; Marquet P; Samadi M; Roché H; Poirot M; Silvente-Poirot S
    J Steroid Biochem Mol Biol; 2017 May; 169():210-218. PubMed ID: 27343991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein I activity in postmenopausal women with breast cancer.
    Wasan KM; Ramaswamy M; Haley J; Dunn BP
    J Pharm Sci; 1997 Jul; 86(7):876-9. PubMed ID: 9232532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of cholesterol, 11-hydroxycorticosteroids and progesterone in plasma from postmenopausal women with breast cancer.
    Smethurst M; Basu TK; Williams DC
    Eur J Cancer (1965); 1975 Oct; 11(10):751-5. PubMed ID: 1204669
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of alterations in plasma lipid profile levels in breast cancer.
    Franky Dhaval Shah ; Shilin Nandubhai Shukla ; Pankaj Manubhai Shah ; Patel HR; Prabhudas Shankerbhai Patel
    Integr Cancer Ther; 2008 Mar; 7(1):33-41. PubMed ID: 18292593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer.
    Nelson ER
    Mol Cell Endocrinol; 2018 May; 466():73-80. PubMed ID: 28919300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol and breast cancer development.
    Danilo C; Frank PG
    Curr Opin Pharmacol; 2012 Dec; 12(6):677-82. PubMed ID: 22867847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between breast cancer, plasma triglycerides, and cholesterol.
    Potischman N; McCulloch CE; Byers T; Houghton L; Nemoto T; Graham S; Campbell TC
    Nutr Cancer; 1991; 15(3-4):205-15. PubMed ID: 1866314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of tamoxifen treatment on serum cholesterol fractions in breast cancer women.
    Dziewulska-Bokiniec A; Wojtacki J; Skokowski J; Kortas B
    Neoplasma; 1994; 41(1):13-6. PubMed ID: 8202188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol and obesity as prognostic factors in breast cancer.
    Tartter PI; Papatestas AE; Ioannovich J; Mulvihill MN; Lesnick G; Aufses AH
    Cancer; 1981 May; 47(9):2222-7. PubMed ID: 7226116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer culprit? A common product of cholesterol may fuel breast tumor growth.
    Moyer MW
    Sci Am; 2014 Apr; 310(4):18. PubMed ID: 24712111
    [No Abstract]   [Full Text] [Related]  

  • 18. Salubrious effect of vitamin C and vitamin E on tamoxifen-treated women in breast cancer with reference to plasma lipid and lipoprotein levels.
    Babu JR; Sundravel S; Arumugam G; Renuka R; Deepa N; Sachdanandam P
    Cancer Lett; 2000 Apr; 151(1):1-5. PubMed ID: 10766415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Level of total cholesterol in serum of patients with breast cancer treated with tamoxifen].
    Wojtacki J; Dziewulska-Bokiniec A
    Pol Tyg Lek; 1993 Jun 7-14; 48(23-24):505-6. PubMed ID: 8170824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of cholesterol and epigenetic changes to the pathophysiology of breast cancer.
    Munir MT; Ponce C; Powell CA; Tarafdar K; Yanagita T; Choudhury M; Gollahon LS; Rahman SM
    J Steroid Biochem Mol Biol; 2018 Oct; 183():1-9. PubMed ID: 29733910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.